| Alles Mark John | 02-Jan-20 | 14-Apr-23 | INED | | In order to pursue other new opportunities taking an executive role within the pharmaceutical industry, which may or may not give rise to a potential conflict of interests |
| 14-Apr-23 | MbAC, MbCC | | In order to pursue other new opportunities taking an executive role within the pharmaceutical industry, which may or may not give rise to a potential conflict of interests |
| Bing Hou | 01-Aug-26 | | ED, AuRep | | |
| Cao Yang | 18-Aug-20 | 10-Jun-26 | J-CoSec | | Resigned as Joint Company Secretary, but will remain in his position as Corporate Vice President, overseeing the Group’s capital markets business. |
| Cao Yanling | 04-Feb-19 | 16-Dec-21 | NED | | |
| Chen Kan | 26-Mar-21 | 14-Jun-24 | NED | | No reasons provided |
| Chin John Francis | 18-Aug-20 | 01-Aug-24 | ED | | Due to retirement |
| Fonseca Rafael | 14-Apr-23 | | INED | | |
| Hu Xubo | 22-Nov-18 | 26-Mar-21 | NED | | |
| Lam Chin Hei | 10-Jun-26 | | J-CoSec | | |
| Li Ming | 22-Nov-18 | 18-Aug-20 | NED | | |
| Li Teng | 22-Nov-18 | 18-Aug-20 | NED | | |
| Li Zhen | 04-Feb-19 | 18-Jun-21 | NED | | |
| Liu Yilun | 16-Dec-21 | 14-Apr-23 | NED | | Due to his own business engagement which requires more of his attention and dedication |
| Liu Ying | 10-Jun-26 | | J-CoSec | | |
| Liu Yiteng | 22-Nov-18 | 18-Jun-21 | COO, ED | | |
| Lung Donald Andrew | 18-Jun-21 | | FD | | |
| 01-Aug-26 | ED, CFO, AuRep, Proc Agt | | To pursue other career opportunities. |
| Lynch Kevin Patrick | 18-Jun-21 | 16-Dec-22 | ED | | Due to retirement |
| Mei Jay | 28-Aug-18 | | Ch, CEO | | |
| Qian Jing | 09-Nov-20 | | INED | | |
| Tang Sheng | 09-Nov-20 | | INED | | |
| Wong Keith Shing Cheung | 18-Aug-20 | 30-Mar-22 | CoSec | | |
| 30-Mar-22 | J-CoSec | | Due to personal work adjustment |
| Wong Wai Chiu | 30-Mar-22 | 10-Jun-26 | J-CoSec | | Resigned. |
